Why did SYNI stock collapse to $0.000001?

The collapse reflects extreme selling, thin float and low liquidity. A sharp gap from **$0.08317158** to **$0.000001** can result from forced selling or delisting risk. Technical oversupply and negative fundamentals also contributed.

Can SYNI stock stage an oversold bounce?

Yes, elevated volume and the steep drop create conditions for a short-term bounce. Traders should use tiny position sizes, strict stops, and target quick profits because rebounds may be short lived.

What is Meyka AI’s view on SYNI stock?

Meyka AI rates SYNI **62.62 (B)** with a HOLD suggestion. The model flags sector, benchmark, and growth factors. Ratings are informational and not personal financial advice.

What price target should traders watch for SYNI stock?

For a short-term scalp watch **$0.01** and for a model recovery scenario the platform projects **$0.00050**. Use these only as scenario guides, not guarantees.

US Stocks

SYNI stock: Synvista Therapeutics (PNK) $0.000001 on 10 Feb 2026, oversold bounce

ByDanny Kontos February 10, 2026

SYNI stock fell to $0.000001 on 10 Feb 2026 during U.S. market hours on the PNK exchange, a near-total collapse from a previous close of $0.08. The drop shows extreme oversold conditions that can trigger a short-term bounce for active traders using tight risk rules. Volume is elevated at 5,229 shares versus a 50-day average of 260, underlining a liquidity spike. We frame this as an oversold bounce trade, not a buy-and-hold thesis, and note the stock trades in the United States in USD.